Optimal carbon dioxide application for organ protection in cardiac surgery  by Martens, S. et al.





G. Wimmer-Greinecker, MD, PhD
A. Moritz, MD, PhD
Background: Cardiac surgery is associated with an important risk of central or
peripheral organ damage, attributed in part to air embolism from incompletely
deaired cardiac chambers. Insufflation of carbon dioxide into the thoracic cavity is
widely used for organ protection in cardiac surgery.
Methods: In patients operated on through a sternotomy, the gas was insufflated
through a standard cardioplegia line (group I, n  10) or a Jackson-Pratt drain
(group II, n 10), with flow rates of 2, 4, and 6 L/min. In patients undergoing mitral
valve surgery through a right anterolateral minithoracotomy, application through a
gas port (group III, n 10) was compared with application through a Veress needle
(group IV, n  10). In groups I and IV measurements were repeated with a gauze
sponge to divert the gas stream.
Results: At a flow of 2 L/min, carbon dioxide levels in the thoracic cavity reached
52% 30% in group I and increased to 81% 27% when a gauze sponge was used.
In group II a level of 91%  5% was achieved. In minimally invasive procedures
carbon dioxide levels reached 92%  6% in group III and 60%  25% in group IV
without a gauze sponge and 97% 2% in group IV with a gauze sponge. Increasing
flow rates from 2 to 6 L/min decreased carbon dioxide levels in the thoracic cavity.
Arterial blood gas analysis did not reveal critical levels of partial pressure of carbon
dioxide at any time.
Conclusions: For optimized carbon dioxide concentrations during cardiac proce-
dures, jet effects in the thoracic cavity have to be avoided. The highest levels were
achieved with infusion lines covered by a gauze sponge or a perforated drain for
conventional operations and a sponge-covered Veress needle or a gas port for
minimally invasive approaches.
Insufflation of carbon dioxide (CO2) to the operative field to prevent cerebralor myocardial damage by means of air embolism has been reported since1957 in cardiac surgery.1 With the advent of minimally invasive valvesurgery, deairing of cardiac chambers has become more difficult, andreplacing air in the operative field with a more soluble gas has become awidely used technique. In recent studies neurocognitive impairment has
been observed in up to 88% of patients after cardiopulmonary bypass (CPB)
procedures, and disturbances might be progressive and persistent.2 Introduction of
air into the CPB circuit, resulting in cerebral microembolization, might contribute to
postoperative cognitive impairment.3 Despite carefully performed deairing proce-
dures, transcranial Doppler studies revealed a large amount of emboli during the first
ejections of the beating heart.4 Air emboli always remain in the arterial circulation
until complete absorption, and they only occasionally dislodge and flow down-
stream.5 CO2 fills the thoracic cavity by means of gravity and replaces air if
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adequately insufflated. Because solubility of CO2 is better
than that of air, occlusion or flow disruption in arteries of
the brain or the heart is thought to be diminished. In 1940,
Moore and Braselton6 showed that the lethal dose of air was
12 times less than that of CO2 injected into the pulmonary
vein. In our institution all patients undergoing cardiac sur-
gery through limited incisions are operated on with CO2
insufflation as a matter of policy.
An indirect method to determine the effectiveness of
CO2 application to the operative field by measurement of
oxygen concentration was presented by Selman and col-
leagues1 in 1967. The aim of our study was to evaluate
different application methods with regard to optimized gas
flow by using direct measurements of CO2 in the thoracic
cavity. Measurements were performed in standard proce-
dures through a median sternotomy and in minimally inva-
sive approaches through limited incisions. Because compli-
cations caused by systemic resorption of CO2 and an
increase of arterial Pco2 with acidosis have been described,
blood gas analyses were evaluated frequently in our pa-
tients.
Patients and Methods
In patients of groups I and II, operations were performed through
a complete median sternotomy. Procedures in group I were aortic
valve replacement (n  4) combined with mitral valve replace-
ment (n  1) or with coronary artery bypass grafting (n  2),
mitral valve repair (n 2), and atrial septal defect closure (n 1).
Procedures in group II were aortic valve replacement (n  2)
combined with coronary artery bypass grafting (n  1), aortic
valve replacement with a conduit (n  2), aortic valve reconstruc-
tion (n  1) combined with replacement of the ascending aorta
(n  1), and mitral valve reconstruction (n  3). Preoperative and
intraoperative data are summarized in Table 1.
After systemic anticoagulation (300 IU/kg Liquemin, Roche),
cannulation of the ascending aorta was performed with a standard
cannula (Jostra AG). For cannulation of the right atrium, we used
a 2-stage cannula or bicaval cannulation for mitral valve proce-
dures, respectively. CPB was instituted with a Quadrox (Jostra
AG) capillary membrane oxygenator. The circuit was primed with
1500 mL of Ringer’s lactate solution, 500 mL of 6% hydroxyethyl
starch, 100 mL of 20% mannitol, and 150 IU/kg heparin. CPB was
conducted with a flow of 2.4 L/min per square meter of body
surface area, rectal temperature was lowered to 30°C  2°C, and
alpha-stat management was applied. Antegrade and retrograde
cold blood cardioplegia were administered in an intermittent fash-
ion. The arresting dose was 1000 mL, and a maintenance dose of
400 mL was infused every 20 minutes. Anesthesia was maintained
with sufentanyl, pancuronium, or propofol, and ventilation was
performed with an O2/N2O mixture establishing an inspired oxy-
gen fraction (FIO2) of 0.5 and aiming at a Pco2 of 35 to 40 mm Hg
before and after CPB. We used intermittent cardiotomy suction
and continuous venting through the apex of the left ventricle or the
left atrium in mitral valve procedures, respectively.
CO2 was applied by using a perfusion line (2-mm inner diam-
eter) sutured to the left side of the pericardium in group I. After
consecutive measurements at flows of 2, 4, and 6 L/min, the
perfusion line was covered with a gauze sponge to divert the gas
stream, and measurements were repeated. Ten minutes after stable
levels of CO2 in the operative field had been reached, arterial blood
gas analyses were performed. Gas flow through the oxygenator and
oxygen concentration (FIO2) were adjusted by the perfusionist,
according to blood gas checks and expectation of Pco2 changes
during gas application. In group II CO2 was applied with a com-
mercially available perforated drain (Jackson-Pratt, Allegiance)
placed in the pericardial sac left and posterior to the heart. Deairing
of cardiac chambers was performed before release of the aortic
crossclamp through the apex of the left ventricle, the ascending
aorta, and the left atrium in mitral valve procedures. The procedure
was repeated on the beating heart. Venting through the ascending
aorta was continued until the heart ejected and extracorporeal
circuit was reduced.
Patients in group III and IV were operated on through right
anterolateral thoracotomies through a 7-cm skin incision. In group
III 7 patients underwent mitral valve repair, and 3 patients under-
went mitral valve replacement. In group IV 9 repairs and 1
replacement were performed on the mitral valve. For patients’
preoperative and intraoperative data, see Table 1. CPB was insti-
tuted after cannulation of the femoral artery and vein (with can-
nulas fabricated by Jostra AG). Cold blood cardioplegic solution
was applied through a needle in the ascending aorta. A transtho-
racic clamp was used for aortic crossclamping (Scanlan Inc). The
management of CPB and anesthesia was not different from that in
our patients operated on through a median sternotomy, except for
selective single-lung intubation to allow deflation of the right lung.
CO2 was insufflated beginning with the start of CPB until the
atrium was closed. In group III a separate gas port with a 5-mm
inner diameter (Endopath, Ethicon) was used. In group IV meas-
urements were performed after introduction of a Veress needle
with a 2-mm inner diameter. Afterward, the needle was covered
TABLE 1. Preoperative and intraoperative data
Group I (n  10) Group II (n  10) Group III (n  10) Group IV (n  10)
Sex 7 males 8 males 3 males 7 males
Age (y) 61 22 60 16 49 25 50 14
Size (cm) 170 11 177 10 165 10 178 7
Weight (kg) 76 13 84 22 66 13 74 10
CPB flow (L/min) 4.4 0.3 4.8 0.6 4.2 0.5 4.6 0.3
CPB (min) 124 32 156 40 134 18 171 34
Crossclamp time (min) 78 31 101 36 83 13 104 22
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with a gauze sponge, and measurements were repeated with gas
flow of 2, 4 and 6 L/min. Blood gas analyses were performed as
described above. For deairing of the cardiac chambers, a vent in
the left atrium and another in the aortic root was used, and the
ascending aorta was punctured with a needle.
We used an infrared CO2 analyzer (BUSE), allowing for meas-
urements of CO2 concentration in the operative field, at the level
of the left ventricular cavity. The analyzer aspirates gas samples
through a plastic tube. Results are indicated with a time delay of a
few seconds and a sensitivity of 0.5%. For blood gas analyses,
ABL System 625 (Radiometer Medical) was used.
The study was approved by our institutional ethics committee.
For statistical analysis, the SAS software package was used (SAS,
Inc). The Duncan multiple range test was applied to test for
significance between the different methods of application and
results of blood gas analyses. Data are presented as mean and SD
of the mean.
Results
CO2 concentrations in the thoracic cavity are depicted for
operations performed through a median sternotomy in Fig-
ure 1 and in Figure 2 for minimally invasive procedures. At
2-L/min flow, CO2 levels in the thoracic cavity reached 52%
 30% in group I and increased to 81%  27% when a
gauze sponge was used (P  .001). In group II a level of
91%  5% was achieved, which was significantly elevated
compared with that in uncovered cardioplegia lines of group
I (P  .001) and slightly higher than that with sponge-
covered lines (not significant). Additional measurements
with 10-L/min flow were performed according to the liter-
ature.7 No increase of CO2 concentrations compared with
lower flow rates could be shown (90%  7% vs 91%  5%
with 2 L, not significant). In minimally invasive procedures
CO2 levels reached 92% 6% in group III and 60% 25%
in group IV without a gauze sponge and 97%  2% in
group IV with a gauze sponge. The highest CO2 concentra-
tions were achieved with sponge-covered Veress needles
and gas port insufflation, respectively (P  .001 vs uncov-
ered Veress needles).
Results of blood gas analyses are shown in Table 2. For
groups I and IV, values are presented for the higher oper-
ative field concentrations achieved with gauze sponges.
Because significant field levels of CO2 have already been
achieved with a flow of 2 L/min, the measurements with 6
L/min were taken after approximately 30 minutes of expo-
sure to a CO2 atmosphere. Our perfusionists increased gas
flow through the oxygenator to avoid systemic accumula-
tion of CO2. This was significant in minimally invasive
procedures of group IV, in which gas flow was increased
from 2.8  0.5 to 3.6  0.6 L/min (P  .0049). As a result
of a slight overcorrection, Pco2 levels in serial blood gas
analyses decreased from 42.3  6.1 mm Hg with 2-L/min
insufflation to 36.9  6.7 mm Hg with 6-L/min CO2 insuf-
flation (not significant). However, systemic Pco2 remained
within normal ranges in all groups (Table 2). FIO2 was
significantly reduced by the pump technicians in group IV,
from 0.45  0.07 to 0.39  0.05 (P  .007), resulting in
lower arterial Po2 values (251  29 mm Hg with 2-L/min
and 158  45 mm Hg with 6-L/min gas insufflation, P 
.016). All blood gas analyses remained within normal ranges,
despite varieties of CO2 field concentration and adaptations of
oxygenator gas flow and oxygen concentration.
There was no perioperative mortality in the study groups.
One patient in group I was reoperated on for bleeding and
recovered with prolonged confusion. One patient in group II
presented with low cardiac output syndrome after double
valve replacement and underwent respirator therapy for 6
days after the operation.
Figure 1. CO2 concentrations measured at the level of the left ventricular cavity, with operations performed through
median sternotomy. Demonstrated are mean, SD (box plots), and range of values (T bars).
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CO2 is used to replace air in the operative field during
cardiac procedures with the assumption that the more sol-
uble CO2 will reduce the amount and sequelae of gaseous
emboli. CO2 might be resorbed already in the cardiac cham-
bers, and therefore the amount of gas bubbles in the ascend-
ing aorta can be reduced, as shown in an echocardiographic
study.7 In addition, embolic bubbles obstructing a peripheral
vessel might be resorbed quicker when they consist of a
high concentration of CO2. For the latter, however, we
found no scientific proof in the literature. It is obvious that
only a significant increase in the CO2 concentration in the
cardiac chambers can influence resorption rates of residual
gas and by this can influence clinical outcome.
There are several methods of CO2 application described
in the literature. Many surgeons use standard perfusion lines
with 2- to 3-mm inner diameter with a flow of 2 to 10 L/min
CO2 to replace air in the thoracic cavity and cardiac cham-
bers. This is done under the assumption that the heavy CO2
will fill the operative field by means of gravity. Shang and
Rosen8 showed that a flow of greater than 5 L/min did not
increase effectiveness of air replacement in the thoracic
cavity. Webb and colleagues7 used a perforated drain (Jack-
son-Pratt) and a flow of 10 L/min CO2, and they demon-
strated a reduction of gas bubbles in the cardiac chambers
visualized by means of transesophageal echocardiography.
Their group did not measure CO2 concentrations in the
operative field directly but concluded from oxygen concen-
trations that they reached CO2 concentrations of 93% and
greater. Our results indicate that concentrations of greater
than 90% are achieved if only 2 L/min is applied. Selman
and coworkers1 showed that greater than 90% of air can be
displaced from the operative field if a CO2 disperser is used.
Increasing flow rates lead to reduced concentrations of CO2
Figure 2. CO2 concentrations measured at the level of the left ventricular cavity, with minimally invasive
procedures. Demonstrated are mean, SD (box plots), and range of values (T bars).










(°C) FIO2 Gas flow
Group I (sponge) 2 80.5 27 38.4 4 210.4 59 30.8 2.4 0.47 0.08 2.6 1.0
4 87.6 19 40.6 10 195.9 80 31.4 2.4 0.48 0.08 2.7 1.3
6 88.2 20 41.6 8 201.8 79 32.0 2.8 0.45 0.12 3.3 1.9
Group II 2 91.4 5 40.6 8 199.3 47 29.6 2.8 0.41 0.09 3.3 1.1
4 93.7 6 39.5 8 176.6 38 30.1 2.7 0.40 0.09 3.6 1.4
6 87.8 20 39.8 10 185.4 72 31.0 2.7 0.40 0.09 3.5 1.6
10 90.3 7 42.4 11 165.0 60 29.6 4.1 0.38 0.11 4.0 1.7
Group III 2 92.3 6 39.9 6 174.9 71 29.9 1.5 0.39 0.07 3.0 1.0
4 90.8 11 39.5 6 177.7 65 30.2 1.7 0.38 0.07 3.4 1.0
6 90.4 12 36.6 5 152.7 73 30.7 2.2 0.40 0.08 4.1 1.3
Group IV (sponge) 2 97.5 2 42.3 6 251.2 29 29.5 1.4 0.45 0.07 2.8 0.5
4 97.2 4 38.8 5 197.3 40 29.2 0.9 0.38 0.06 3.5 0.6
6 98.9 1 36.9 7 157.9 45 30.1 2.6 0.39 0.05 3.6 0.6
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in the thoracic cavity if 1⁄4-inch tubing was used for gas
application. Even if a knitted blood vessel prosthesis was
used as a disperser, CO2 levels decreased if more than 7
L/min CO2 were applied.
These results are confirmed by our direct measurements
in the thoracic cavity. We showed that application is effec-
tive if a commercially available perforated drain (Jackson-
Pratt) or a simple cardioplegia line covered with a gauze
sponge is used in cardiac procedures. Our results in mini-
mally invasive procedures indicate that insufflation through
a gas port or dividing the gas stream of an endoscopic
needle with a gauze sponge increases CO2 concentration in
the operative field. Uncovered lines or endoscopic needles
showed significantly lower CO2 concentrations. Most prob-
ably, high gas jets flushed the operative field, and the
generated gas stream dragged air into the pericardial sac.
Flooding of the operative field by means of gravity does not
occur with these gas jets. Even with diverted gas jets,
concentrations tended to decrease at higher flow rates.
Several authors described an increase of CO2 in blood
with acidosis when CO2 was insufflated into the thoracic
cavity.9-12 This is in part dependent on the use of cardiot-
omy suction or venting. There were methods described to
monitor CO2 levels in the cardiotomy reservoir and to
prevent accumulation of CO2 by flushing excessive CO2
with oxygen in the oxygenator.12 In our patients the Pco2 in
arterial blood samples did not reach critical levels, although
conventional cardiotomy suction and venting was used, and
CO2 was applied from the start of extracorporeal circulation
until release of the aortic crossclamp. Because of lack of
experience and reliable data with pump management under
these conditions, our perfusionists corrected the gas flow
according to their expectations and results of blood gas
analyses. However, this led to significant but clinically
irrelevant overcorrection in group IV. With increasing gas
flows, the oxygen concentration provided (FIO2) was re-
duced, and consecutively, Po2 levels in arterial blood sam-
ples declined to more physiologic levels.
Concentrations of greater than 90% of CO2 in the oper-
ative field are possible with our means of application to
achieve effective reduction of gaseous cerebral and coro-
nary artery emboli in cardiac surgery. A gas flow of 2 L/min
is sufficient, as long as gas jets are diverted. Gas concen-
trations did not increase with flow, most probably because
higher exit velocity causes jets, flushing the thoracic cavity
with room air. Systemic accumulation of CO2 with severe
acidosis was not observed. However, extracorporeal circu-
lation management had to be adapted.
References
1. Selman MW, McAlpine WA, Albregt H, Ratan R. An effective
method of replacing air in the chest with CO2 during open heart
surgery. J Thorac Cardiovasc Surg. 1967;53:618-22.
2. McKhann GM, Goldsborough LM, Borowicz MS, et al. Cognitive
outcome after coronary artery bypass: a one-year prospective study.
Ann Thorac Surg. 1997;63:510-5.
3. Borger MA, Peniston CM, Weisel RD, Vasiliou M, Green REA,
Feindl CM. Neuropsychologic impairment after coronary bypass sur-
gery: effect of gaseous microemboli during perfusionist interventions.
J Thorac Cardiovasc Surg. 2001;121:743-9.
4. van der Linden J, Casimir-Ahn H. When do cerebral emboli appear
during open heart operations? A transcranial Doppler study. Ann
Thorac Surg. 1991;51:237-41.
5. Branger AB, Eckmann DM. Theoretical and experimental intravascu-
lar gas embolism absorption dynamics. J Appl Physiol. 1999;87:1287-
95.
6. Moore RM, Braselton CW. Injections of air and carbon dioxide into a
pulmonary vein. Ann Surg. 1940;112:212.
7. Webb WR, Harrison LH, Helmcke FR, et al. Carbon dioxide field
flooding minimizes residual intracardiac air after open heart opera-
tions. Ann Thorac Surg. 1997;64:1489-91.
8. Shang W, Rosen M. Carbon dioxide in the prevention of air embolism
during open heart surgery. Thorax. 1968;23:194-6.
9. Burbank A, Ferguson TB, Burford TH. Carbon dioxide flooding of the
chest in open heart surgery: a potential hazard. J Thorac Cardiovasc
Surg. 1965;50:691-8.
10. Lippmann M. Complications of CO2 field flooding the surgical field in
open heart surgery: an old technique revisited. Anesth Analg. 1998;
87:978-9.
11. O’Connor BR, Kussman BD, Kyung WP. Severe hypercarbia during
cardiopulmonary bypass: a complication of CO2 flooding of the sur-
gical field. Anaesth Analg. 1998;86:264-6.
12. Nadolny ED, Svensson LG. Carbon dioxide field flooding techniques
for open heart surgery: monitoring and minimizing potential adverse
effects. Perfusion. 2000;15:151-3.
Martens et al Cardiopulmonary Support and Physiology
The Journal of Thoracic and Cardiovascular Surgery ● Volume 124, Number 2 391
CS
P
